Klin Farmakol Farm. 2026;40(2):129-133 | DOI: 10.36290/far.2026.007

The role of glucocorticoids in endocrinology

Pavel Cee, Jan Drugda, Filip Gabalec
IV. interní klinika Fakultní nemocnice Hradec Králové a Lékařská fakulta Hradec Králové Univerzity Karlovy v Praze

Glucocorticoids represent a fundamental group of hormones that play a key role in the regulation of metabolism, immune response, and adaptation to stress. Their widespread use in medicine is based on potent anti-inflammatory and immunosuppressive effects; however, long-term therapy is associated with the risk of serious adverse effects. This article focuses on hypercortisolism, both in the form of endogenous Cushing's syndrome and the more frequent exogenous form related to long-term glucocorticoid administration. Clinical manifestations, diagnostic procedures, and current therapeutic options including surgical, pharmacological, and radiotherapeutic approaches are discussed. Another major area addressed is adrenal insufficiency, with emphasis on etiology, clinical manifestations, diagnostic methods, and glucocorticoid and mineralocorticoid replacement therapy. Special attention is given to glucocorticoid-induced adrenal insufficiency, which is currently the most common form of this disorder, and to glucocorticoid withdrawal syndrome. Principles of safe dose tapering and prevention of adrenal crisis are outlined. The aim of this review is to provide a comprehensive overview of the role of glucocorticoids in endocrinology, with an emphasis on clinical context, current recommendations, and practical aspects of treatment that are crucial for everyday medical practice.

Keywords: glucocorticoids, Cushing's syndrome, adrenal insufficiency, adrenal crisis, glucocorticoid withdrawal.

Received: October 22, 2025; Revised: January 8, 2026; Accepted: February 18, 2026; Published: July 1, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cee P, Drugda J, Gabalec F. The role of glucocorticoids in endocrinology. Klin Farmakol Farm. 2026;40(2):129-133. doi: 10.36290/far.2026.007.
Download citation

References

  1. Scherholz ML, Schlesinger N, Androulakis IP. Chronopharmacology of Glucocorticoids. Adv Drug Deliv Rev. 2019;151-152:245-261. Go to original source...
  2. Pofi R, Caratti G, Ray DW, et al. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad? Endocr Rev. 2023;44(6):975-1011. Go to original source...
  3. Nieman LK, Castinetti F, Newell-Price J, et al. Cushing syndrome. Nat Rev Dis Primers. 2025;11(1):1-25. Go to original source...
  4. Chaudhry HS, Singh G. Cushing Syndrome (Archived). In: StatPearls [Internet]. StatPearls Publishing; 2025 [cited 24.8.2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470218/.
  5. Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. In: StatPearls [Internet]. StatPearls Publishing; 2025 [cited 28.8.2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK531462/.
  6. Cai Y, Ren L, Tan S, et al. Mechanism, diagnosis, and treatment of cyclic Cushing's syndrome: A review. Biomed Pharmacother. 2022;153:113301. Go to original source...
  7. Savas M, Mehta S, Agrawal N, et al. Approach to the Patient: Diagnosis of Cushing Syndrome. J Clin Endocrinol Metab. 2022;107(11):3162-3174. Go to original source...
  8. Juszczak A, Morris D, Grossman A. Cushing's Syndrome. In: Endotext [Internet]. MDText.com, Inc.; 2000 [cited 24.8.2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279088/.
  9. Nieman LK, Biller BMK, Findling JW, et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807-2831. Go to original source...
  10. Detomas M, Deutschbein T, Altieri B. Medical Therapy of Endogenous Cushing's Syndrome with Steroidogenesis Inhibitors: Treatment Rationale, Available Drugs, and Therapeutic Effects. Exp Clin Endocrinol Diabetes. 2024;132:723-731. Go to original source...
  11. Huecker MR, Bhutta BS, Dominique E. Adrenal Insufficiency. In: StatPearls [Internet]. StatPearls Publishing; 2025 [cited 7.9.2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK441832/.
  12. Lewis A, Thant AA, Aslam A, et al. Diagnosis and management of adrenal insufficiency. Clin Med. 2023;23(2):115-118. Go to original source...
  13. Lundholm MD, Ambalavanan J, Rao PP. Primary adrenal insufficiency in adults: When to suspect, how to diagnose and manage. Cleve Clin J Med. 2024;91(9):553-562. Go to original source...
  14. National Institute for Health and Care Excellence. Adrenal insufficiency: identification and management [Internet]. National Institute for Health and Care Excellence (NICE); 2024 [cited 28.8.2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK609655/.
  15. Elshimy G, Chippa V, Kaur J, et al. Adrenal Crisis. In: StatPearls [Internet]. StatPearls Publishing; 2025 [cited 28.8.2025]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK499968/.
  16. Borresen SW, Klose M, Glintborg D, et al. Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. J Clin Endocrinol Metab. 2022;107(7):2065-2076. Go to original source...
  17. Nachawi N, Li D, Lansang MC. Glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome: Two sides of the same coin. Cleve Clin J Med. 2024;91(4):245-255. Go to original source...
  18. Priya G, Laway BA, Ayyagari M, et al. The Glucocorticoid Taper: A Primer for the Clinicians. Indian J Endocrinol Metab. 2024;28(4):350-362. Go to original source...
  19. Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. J Clin Endocrinol Metab. 2024;109(7):1657-1683. Go to original source...
  20. Pelewicz K, Miśkiewicz P. Glucocorticoid Withdrawal - An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice. Diagnostics. 2021;11(4):728. Go to original source...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.